<p>In this study we profile the epigenomic enhancer landscapes of CLL B cells (CD19+/CD5+) harvested from peripheral blood of patients from our Center. Included are results of ChIPseq profiling using chromatin immunoprecipitation of the enhancer histone mark H3K27ac (acetylated lysine 27 on histone H3), and open chromatin profiles using ATAC-seq (assay for transposase accessible chromatin). These profiles are used to define the global enhancer and super enhancer landscape of CLL B cells, and to derive active transcription factor networks associated with this disease. Also included are H3K27ac ChIP-seq and ATAC-seq datasets for non-CLL B cells obtained from the peripheral blood of normal adult donors.</p>

Enhancer Mapping in Chronic Lymphocytic Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell study with ATAC-seq, ChIP-Seq + 1 more data on dbGaP (28 participants)

Enhancer Mapping in Chronic Lymphocytic Leukemia

Description

Applying For Access

Summary